83 related articles for article (PubMed ID: 12624151)
21. Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population.
Nakazato H; Suzuki K; Matsui H; Ohtake N; Nakata S; Yamanaka H
Br J Cancer; 2003 Aug; 89(4):691-6. PubMed ID: 12915880
[TBL] [Abstract][Full Text] [Related]
22. Rapid detection of the two common mutations in Ashkenazi Jewish patients with mucolipidosis type IV.
Wang ZH; Zeng B; Pastores GM; Raksadawan N; Ong E; Kolodny EH
Genet Test; 2001; 5(2):87-92. PubMed ID: 11551108
[TBL] [Abstract][Full Text] [Related]
23. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin.
Shahrabani-Gargir L; Shomrat R; Yaron Y; Orr-Urtreger A; Groden J; Legum C
Genet Test; 1998; 2(4):293-6. PubMed ID: 10464606
[TBL] [Abstract][Full Text] [Related]
24. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
Roa BB; Boyd AA; Volcik K; Richards CS
Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
[TBL] [Abstract][Full Text] [Related]
25. A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome.
Ben-Yosef T; Ness SL; Madeo AC; Bar-Lev A; Wolfman JH; Ahmed ZM; Desnick RJ; Willner JP; Avraham KB; Ostrer H; Oddoux C; Griffith AJ; Friedman TB
N Engl J Med; 2003 Apr; 348(17):1664-70. PubMed ID: 12711741
[No Abstract] [Full Text] [Related]
26. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
Oddoux C; Struewing JP; Clayton CM; Neuhausen S; Brody LC; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K
Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192
[TBL] [Abstract][Full Text] [Related]
27. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
Tobias DH; Eng C; McCurdy LD; Kalir T; Mandelli J; Dottino PR; Cohen CJ
Gynecol Oncol; 2000 Aug; 78(2):148-51. PubMed ID: 10926794
[TBL] [Abstract][Full Text] [Related]
28. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
Hamel N; Kotar K; Foulkes WD
BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
[TBL] [Abstract][Full Text] [Related]
29. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population.
Whitney MA; Jakobs P; Kaback M; Moses RE; Grompe M
Hum Mutat; 1994; 3(4):339-41. PubMed ID: 8081385
[TBL] [Abstract][Full Text] [Related]
30. The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews.
Quintana-Murci L; Gal I; Bakhan T; Quach H; Sayar SH; Shiri-Sverdlov R; Baruch RG; McElreavey K; Dagan E; Narod S; Friedman E
Fam Cancer; 2005; 4(2):85-8. PubMed ID: 15951957
[TBL] [Abstract][Full Text] [Related]
31. Cystic fibrosis in Jews: frequency and mutation distribution.
Kerem B; Chiba-Falek O; Kerem E
Genet Test; 1997; 1(1):35-9. PubMed ID: 10464623
[TBL] [Abstract][Full Text] [Related]
32. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
[TBL] [Abstract][Full Text] [Related]
33. RNASEL Arg462Gln polymorphism and prostate cancer in PLCO.
Daugherty SE; Hayes RB; Yeager M; Andriole GL; Chatterjee N; Huang WY; Isaacs WB; Platz EA
Prostate; 2007 Jun; 67(8):849-54. PubMed ID: 17407163
[TBL] [Abstract][Full Text] [Related]
34. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
Neuhausen S; Gilewski T; Norton L; Tran T; McGuire P; Swensen J; Hampel H; Borgen P; Brown K; Skolnick M; Shattuck-Eidens D; Jhanwar S; Goldgar D; Offit K
Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092
[TBL] [Abstract][Full Text] [Related]
35. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
[TBL] [Abstract][Full Text] [Related]
36. X-linked spondyloepiphyseal dysplasia tarda: a novel SEDL mutation in a Jewish Ashkenazi family and clinical intervention considerations.
Bar-Yosef U; Ohana E; Hershkovitz E; Perlmuter S; Ofir R; Birk OS
Am J Med Genet A; 2004 Feb; 125A(1):45-8. PubMed ID: 14755465
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) gene.
Lehrer S; Diamond EJ; Stone NN; Droller MJ; Stock RG; Stone M; Bajwa A; Kornreich R
Urol Oncol; 2003; 21(2):101-4. PubMed ID: 12856637
[TBL] [Abstract][Full Text] [Related]
38. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
Vazina A; Baniel J; Yaacobi Y; Shtriker A; Engelstein D; Leibovitz I; Zehavi M; Sidi AA; Ramon Y; Tischler T; Livne PM; Friedman E
Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
[TBL] [Abstract][Full Text] [Related]
39. RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans.
Shea PR; Ishwad CS; Bunker CH; Patrick AL; Kuller LH; Ferrell RE
Prostate; 2008 Mar; 68(4):354-9. PubMed ID: 18189233
[TBL] [Abstract][Full Text] [Related]
40. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
